Media Coverage
May 28, 2024
PreciseDx Announces Poster Presentation for Breast Cancer Recurrence Test
See More
May 28, 2024
PreciseDx Announces Poster Presentation for Breast Cancer Recurrence Test
See More
Media Coverage
Apr 25, 2024
PathAI Enters Partnership With Google Cloud, Cardiometabolic Clinical Trials Platform, DNA/RNA Extraction Kits, More
See More
Apr 25, 2024
PathAI Enters Partnership With Google Cloud, Cardiometabolic Clinical Trials Platform, DNA/RNA Extraction Kits, More
See More
Media Coverage
Apr 25, 2024
Novo Nordisk Partnership, Mission Bio Updates Platform, PathAI, Google Cloud Team Up, More
See More
Apr 25, 2024
Novo Nordisk Partnership, Mission Bio Updates Platform, PathAI, Google Cloud Team Up, More
See More
Media Coverage
Apr 20, 2024
UCLA And PreciseDx Announce New Collaboration To Advance AI-Enabled Predictions And Risk Mitigation For Triple-Negative Breast Cancer Recurrence
See More
Apr 20, 2024
UCLA And PreciseDx Announce New Collaboration To Advance AI-Enabled Predictions And Risk Mitigation For Triple-Negative Breast Cancer Recurrence
See More
Media Coverage
Apr 9, 2024
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
See More
Apr 9, 2024
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
See More
Media Coverage
Apr 9, 2024
UCLA partners with PreciseDx to evaluate novel test for breast cancer recurrence
See More
Apr 9, 2024
UCLA partners with PreciseDx to evaluate novel test for breast cancer recurrence
See More
Media Coverage
Apr 8, 2024
Consultant UCLA, PreciseDx to Develop AI-Powered Breast Cancer Recurrence Tool for Early Detection
See More
Apr 8, 2024
Consultant UCLA, PreciseDx to Develop AI-Powered Breast Cancer Recurrence Tool for Early Detection
See More
Media Coverage
Apr 4, 2024
UCLA and PreciseDx Collaborate on AI-Powered Breast Cancer Recurrence Diagnostics
See More
Apr 4, 2024
UCLA and PreciseDx Collaborate on AI-Powered Breast Cancer Recurrence Diagnostics
See More
Apr 2, 2024
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
See More
Apr 2, 2024
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
See More
Media Coverage
Apr 2, 2024
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
See More
Apr 2, 2024
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
See More
No results.
Contact us today to learn more about PreciseBreast.
